Disease on EC 1.14.11.16 - peptide-aspartate beta-dioxygenase
Please use the Disease Search for a specific query.
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
Abortion, Missed
[Expression of aspartyl-(asparaginyl) beta-hydroxylase in villi in patients with missed abortion]
Abortion, Spontaneous
Role of aspartyl-(asparaginyl) beta-hydroxylase in placental implantation: Relevance to early pregnancy loss.
Bile Duct Neoplasms
Detection of human aspartyl (asparaginyl) beta-hydroxylase and homeobox B7 mRNA in brush cytology specimens from patients with bile duct cancer.
Breast Neoplasms
Cytoplasmic location of factor-inhibiting hypoxia-inducible factor is associated with an enhanced hypoxic response and a shorter survival in invasive breast cancer.
Breast Neoplasms
DNA methylation analysis of the HIF-1? prolyl hydroxylase domain genes PHD1, PHD2, PHD3 and the factor inhibiting HIF gene FIH in invasive breast carcinomas.
Breast Neoplasms
The key hypoxia regulated gene CAIX is upregulated in basal-like breast tumours and is associated with resistance to chemotherapy.
Breast Neoplasms
[Expression of ASPH Gene in Invasive Breast Cancer and Its Clinical Significance in Promoter Methylation].
Carcinoma
Aspartyl-(asparaginyl)-beta-hydroxylase regulates hepatocellular carcinoma invasiveness.
Carcinoma
Co-targeting of multiple microRNAs on factor-inhibiting hypoxia-inducible factor (FIH) gene for the pathogenesis of head and neck carcinomas.
Carcinoma
Factor-inhibiting hypoxia-inducible factor expression in patients with high-risk locally advanced renal cell carcinoma and its relationship with tumor progression.
Carcinoma
Human aspartyl (asparaginyl) beta-hydroxylase monoclonal antibodies: potential biomarkers for pancreatic carcinoma.
Carcinoma
Prognostic value of aspartyl (asparaginyl)-beta-hydroxylase/humbug expression in non-small cell lung carcinoma.
Carcinoma, Hepatocellular
Aspartyl-(asparaginyl)-beta-hydroxylase regulates hepatocellular carcinoma invasiveness.
Carcinoma, Hepatocellular
Aspartyl-asparagyl beta hydroxylase over-expression in human hepatoma is linked to activation of insulin-like growth factor and notch signaling mechanisms.
Carcinoma, Hepatocellular
Expression of aspartyl beta-hydroxylase and its clinicopathological significance in hepatocellular carcinoma.
Carcinoma, Hepatocellular
Monoclonal antibodies against human aspartyl (asparaginyl) beta-hydroxylase developed by DNA immunization.
Carcinoma, Hepatocellular
Overexpression of aspartyl-(asparaginyl)-beta-hydroxylase in hepatocellular carcinoma is associated with worse surgical outcome.
Carcinoma, Hepatocellular
Prognostic value of humbug gene overexpression in stage II colon cancer.
Carcinoma, Hepatocellular
Prolyl hydroxylase domain protein 3 and asparaginyl hydroxylase factor inhibiting HIF-1 levels are predictive of tumoral behavior and prognosis in hepatocellular carcinoma.
Carcinoma, Renal Cell
Factor-inhibiting hypoxia-inducible factor expression in patients with high-risk locally advanced renal cell carcinoma and its relationship with tumor progression.
Carcinoma, Renal Cell
[Growth Regulation of Factor Inhibiting Hypoxia-Inducible Factor in Renal Carcinoma Cells].
Cholangiocarcinoma
Antisense oligodeoxynucleotides directed against aspartyl (asparaginyl) beta-hydroxylase suppress migration of cholangiocarcinoma cells.
Cholangiocarcinoma
Aspartate beta-hydroxylase promotes cholangiocarcinoma progression by modulating RB1 phosphorylation.
Cholangiocarcinoma
Clinicopathological correlates of aspartyl (asparaginyl) beta-hydroxylase over-expression in cholangiocarcinoma.
Cholangiocarcinoma
Prognostic value of humbug gene overexpression in stage II colon cancer.
Cholangiocarcinoma
Targeting Aspartate Beta-Hydroxylase with the Small Molecule Inhibitor MO-I-1182 Suppresses Cholangiocarcinoma Metastasis.
Fetal Alcohol Spectrum Disorders
Ethanol inhibition of aspartyl-asparaginyl-beta-hydroxylase in fetal alcohol spectrum disorder: potential link to the impairments in central nervous system neuronal migration.
Glioblastoma
The Role of Factor Inhibiting HIF (FIH-1) in Inhibiting HIF-1 Transcriptional Activity in Glioblastoma Multiforme.
Kidney Neoplasms
Factor inhibiting HIF (FIH-1) promotes renal cancer cell survival by protecting cells from HIF-1?-mediated apoptosis.
Myocardial Infarction
Double knockdown of prolyl hydroxylase and factor-inhibiting hypoxia-inducible factor with nonviral minicircle gene therapy enhances stem cell mobilization and angiogenesis after myocardial infarction.
Neoplasm Metastasis
Expression of aspartyl beta-hydroxylase and its clinicopathological significance in hepatocellular carcinoma.
Neoplasm Metastasis
Targeting Aspartate Beta-Hydroxylase with the Small Molecule Inhibitor MO-I-1182 Suppresses Cholangiocarcinoma Metastasis.
Neoplasms
A hypoxic niche regulates glioblastoma stem cells through hypoxia inducible factor 2 alpha.
Neoplasms
Antisense oligonucleotides selectively regulate aspartyl beta-hydroxylase and its truncated protein isoform in vitro but distribute poorly into A549 tumors in vivo.
Neoplasms
Aspartate beta-hydroxylase promotes cholangiocarcinoma progression by modulating RB1 phosphorylation.
Neoplasms
Aspartyl-asparagyl beta hydroxylase over-expression in human hepatoma is linked to activation of insulin-like growth factor and notch signaling mechanisms.
Neoplasms
Clinicopathological correlates of aspartyl (asparaginyl) beta-hydroxylase over-expression in cholangiocarcinoma.
Neoplasms
Detection of human aspartyl (asparaginyl) beta-hydroxylase and homeobox B7 mRNA in brush cytology specimens from patients with bile duct cancer.
Neoplasms
Expression of aspartyl beta-hydroxylase and its clinicopathological significance in hepatocellular carcinoma.
Neoplasms
Expression of HIF-2a in clear-cell renal cell carcinoma independently predicts overall survival.
Neoplasms
Factor-inhibiting hypoxia-inducible factor expression in patients with high-risk locally advanced renal cell carcinoma and its relationship with tumor progression.
Neoplasms
Investigation of FIH-1 and SOCS3 expression in KRAS mutant and wild-type patients with colorectal cancer.
Neoplasms
Isolation and characterization of human antibodies targeting human aspartyl (asparaginyl) beta-hydroxylase.
Neoplasms
Regulation of IL-1?-induced NF-?B by hydroxylases links key hypoxic and inflammatory signaling pathways.
Neoplasms
Role of the aspartyl-asparaginyl-beta-hydroxylase gene in neuroblastoma cell motility.
Neoplasms
Targeting Aspartate Beta-Hydroxylase with the Small Molecule Inhibitor MO-I-1182 Suppresses Cholangiocarcinoma Metastasis.
Neoplasms
The distribution and expression profiles of human Aspartyl/Asparaginyl beta-hydroxylase in tumor cell lines and human tissues.
Neoplasms
The key hypoxia regulated gene CAIX is upregulated in basal-like breast tumours and is associated with resistance to chemotherapy.
Neoplasms
Transcriptional activity and Sp 1/3 transcription factor binding to the P1 promoter sequences of the human AbetaH-J-J locus.
Neoplasms
[Expression of human aspartyl beta-hydroxylase and preparation of its monoclonal antibody].
Neoplasms
[Research on Relationship of HIF-1 Signaling Pathway and Postmenstrual Osteoporosis].
Neoplasms
[The distribution and expression pro-files of Aspartyl/Asparaginyl beta-hydroxylase (ASPH) in some tumorous cell lines and tissues]
Neuroblastoma
Differential growth factor regulation of aspartyl-(asparaginyl)-beta-hydroxylase family genes in SH-Sy5y human neuroblastoma cells.
Neuroblastoma
Role of the aspartyl-asparaginyl-beta-hydroxylase gene in neuroblastoma cell motility.
Squamous Cell Carcinoma of Head and Neck
Co-targeting of multiple microRNAs on factor-inhibiting hypoxia-inducible factor (FIH) gene for the pathogenesis of head and neck carcinomas.
html completed